Skip to content

Acupressure and anxiety in women with gestational diabetes

Effect of acupressure on the rate and severity of anxiety in women with gestational diabetes in intervention and placebo group

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201206246247N8
Enrollment
60
Registered
2012-09-15
Start date
2011-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety-Post-traumatic stress disorder. F43.0 (Post-traumatic stress disorder) and F41.1 (Generalized anxiety disorder)

Interventions

Intervention 1: The intervention in the experimental group was acupressure at the point of P7 for five minutes on each side of the body, three times a day for four consecutive days. Intervention 2: Th
The intervention in the experimental group was acupressure at the point of P7 for five minutes on each side of the body, three times a day for four consecutive days.
The intervention on the control or placebo group was touching instead of acupressure at the point of P7 for five minutes on each side of the body, three times a day for four consecutive days.

Sponsors

Vice Chancellor for Research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 42 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All women aged between 15 and 42 years old, who attended and hospitalized in the Akbarabadi Hospital, the High Risk Obstetrical Unit between August 23, 2011, and October 23, 2011, for treatment of gestational diabetes, who mentioned the feeling of anxiety and no previous experience of acupressure, and signed the written informed consent. Exclusion criteria: not participating in the trial for any reason, and the subjects in the experimental group who did not feel the heavy and numbness feelings during the intervention (acupressure) at the selective point.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety and its severity. Timepoint: at pre-test (before the intervention) and post-test (at the end of the fourth day of the intervention). Method of measurement: a questionnaire of maternal anxiety and the Visual analogue scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farideh Bastani

Faculty of Nursing and Midwifery, Tehran University of Medical Sciences

f-bastani@sina.tums.ac.ir+98 21 6105 4102

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026